olaparib,bevacizumab
Roche,Merck,Astrazeneca
['ovarian', 'brca', 'olaparib']
positive os data with olaparib in hrd+ ovarian cancer patients even when patients with brca mutations are excluded 
MD PhD, Gyn Oncology @az_delta @uzleuven #gyncsm #bcsm